Edinburgh Research Explorer

MAP4K family kinases act in parallel to MST1/2 to activate LATS1/2 in the Hippo pathway

Research output: Contribution to journalArticle

  • Zhipeng Meng
  • Toshiro Moroishi
  • Violaine Mottier-Pavie
  • Steven W Plouffe
  • Carsten G Hansen
  • Audrey W Hong
  • Hyun Woo Park
  • Jung-Soon Mo
  • Wenqi Lu
  • Shicong Lu
  • Fabian Flores
  • Fa-Xing Yu
  • Georg Halder
  • Kun-Liang Guan

Related Edinburgh Organisations

Original languageEnglish
Pages (from-to)8357
JournalNature Communications
Volume6
DOIs
StatePublished - 5 Oct 2015

Abstract

The Hippo pathway plays a central role in tissue homoeostasis, and its dysregulation contributes to tumorigenesis. Core components of the Hippo pathway include a kinase cascade of MST1/2 and LATS1/2 and the transcription co-activators YAP/TAZ. In response to stimulation, LATS1/2 phosphorylate and inhibit YAP/TAZ, the main effectors of the Hippo pathway. Accumulating evidence suggests that MST1/2 are not required for the regulation of YAP/TAZ. Here we show that deletion of LATS1/2 but not MST1/2 abolishes YAP/TAZ phosphorylation. We have identified MAP4K family members--Drosophila Happyhour homologues MAP4K1/2/3 and Misshapen homologues MAP4K4/6/7-as direct LATS1/2-activating kinases. Combined deletion of MAP4Ks and MST1/2, but neither alone, suppresses phosphorylation of LATS1/2 and YAP/TAZ in response to a wide range of signals. Our results demonstrate that MAP4Ks act in parallel to and are partially redundant with MST1/2 in the regulation of LATS1/2 and YAP/TAZ, and establish MAP4Ks as components of the expanded Hippo pathway.

ID: 24501628